Association of reimbursement policy and urologists׳ characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer11Funding: This work was supported by the American Cancer Society, Intramural Research Department, Atlanta, GA.-Reference-Cited by-同舟云学术

Association of reimbursement policy and urologists׳ characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer11Funding: This work was supported by the American Cancer Society, Intramural Research Department, Atlanta, GA.

Published:2014-08 Issue:6 Volume:32 Page:748-760
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Quek Ruben G.W.,Master Viraj A.,Portier Kenneth M.,Ward Kevin C.,Lin Chun Chieh,Virgo Katherine S.,Lipscomb Joseph

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference36 articles.

1. Additional Related References: Association of reimbursement policy and urologists׳ medical school affiliation on the use of medical androgen deprivation therapy for clinically localized prostate cancer. 〈http://tinyurl.com/JUIdea1AddRef〉.

2. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States;Gilbert;Urol Oncol,2011

3. American society of clinical oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer;Loblaw;J Clin Oncol,2004

4. Patients and partners lack knowledge of androgen deprivation therapy side effects;Walker;Urol Oncol,2013

5. Guideline for the management of clinically localized prostate cancer: 2007 update;Thompson;J Urol,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life;Urology;2021-09

2. Sensitivity of Medicare Data to Identify Oncologists;JNCI Monographs;2020-05-01

3. Physician and facility drivers of spending variation in locoregional prostate cancer;Cancer;2020-04-15

4. Race and Time to Receipt of Androgen Deprivation Therapy Among Men With Metastatic Prostate Cancer;Journal of the National Medical Association;2019-06

5. Association Between Reimbursement Incentives and Physician Practice in Oncology;JAMA Oncology;2019-06-01